FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to pharmaceutics and medicine, more specifically to a new chemical compound, a 3-(2,2,2-trimethylhydrazinium)propionate-bromnicotinate 3-(2,2,2-trimethylhydrazinium)potassium propionate derivative, (CH3)3N+HCH2CH2COOKRCOO- wherein shows antiischemic activity.
EFFECT: preparing the compound showing high antiischemic activity.
1 tbl, 1 ex
Title | Year | Author | Number |
---|---|---|---|
3-(2,2,2-TRIMETHYLHYDRAZINIUM) PROPIONATE DERIVATIVE - POTASSIUM GLYCINATE 3-(2,2,2-TRIMETHYLHYDRAZINIUM) PROPIONATE | 2011 |
|
RU2457198C1 |
3-(2,2,2-TRIMETHYLHYDRAZINIUM) PROPIONATE-NICOTINATE 3-(2,2,2-TRIMETHYLHYDRAZINIUM) POTASSIUM PROPIONATE DERIVATIVE EXHIBITING ANTIISCHEMIC ACTIVITY | 2011 |
|
RU2458054C1 |
3-(2,2,2-TRIMETHYLHYDRAZINIUM) PROPIONATE-5-NICOTINATE HYDROXIDE 3-(2,2,2-TRIMETHYLHYDRAZINIUM) POTASSIUM PROPIONATE DERIVATIVE EXHIBITING ANTIISCHEMIC ACTIVITY | 2011 |
|
RU2457202C1 |
3-(2,2,2-TRIMETHYLHYDRAZINIUM) PROPIONATE DERIVATIVE - 3-(2,2,2-TRIMETHYLHYDRAZINIUM) POTASSIUM PROPIONATE 5-BROMNICOTINATE EXHIBITING ENDOTHELIOPROTECTIVE ACTIVITY | 2011 |
|
RU2467745C1 |
3-(2,2,2-TRIMETHYLHYDRAZINIUM) PROPIONATE DERIVATIVE - 3-(2,2,2-TRIMETHYLHYDRAZINIUM) POTASSIUM PROPIONATE GLYCINATE EXHIBITING ENDOTHELIOPROTECTIVE ACTIVITY | 2011 |
|
RU2467748C1 |
3-(2,2,2-TRIMETHYLHYDRAZINIUM) PROPIONATE DERIVATIVE - 3-(2,2,2-TRIMETHYLHYDRAZINIUM) POTASSIUM PROPIONATE 5-NICOTINATE HYDROXIDE EXHIBITING ENDOTHELIOPROTECTIVE ACTIVITY | 2011 |
|
RU2467744C1 |
3-(2,2,2-TRIMETHYLHYDRAZINIUM) PROPIONATE DERIVATIVE -3-(2,2,2-TRIMETHYLHYDRAZINIUM) POTASSIUM PROPIONATE NICOTINATE DERIVATIVE EXHIBITING ENDOTHELIOPROTECTIVE ACTIVITY | 2011 |
|
RU2465268C1 |
METHOD FOR SYNTHESIS OF DIHYDRATE OF 3-(2,2,2-TRIMETHYLHYDRAZINIUM)-PROPIONATE | 2008 |
|
RU2404159C2 |
METHOD FOR INHIBITING NUCLEAR FACTOR KAPPA B WITH USE OF 5-HYDROXYNICOTINATE 3-(2,2,2-TRIMETHYLHYDRAZINIUM) POTASSIUM PROPIONATE IN CELL CULTURE | 2017 |
|
RU2674443C1 |
ANTIISHEMIC AGENT | 2008 |
|
RU2384327C1 |
Authors
Dates
2012-08-20—Published
2011-05-31—Filed